Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 12, 2018
Patent Application Number
15501079
Date Filed
August 3, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (1b), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
